Institute of Microecological Health and Medicine
Contact Hotline:400-066-8611
CN EN
Research
Research
Contact Us
  • PHONE:400-066-8611
  • EMAIL:
  • ADD:5th Floor, Building 5, Changping Life Valley Industrial Base, No. 79, Shuangying West Road, Science and Technology Park, Changping District, Beijing
Application for Research Funding Project

Microecology Health and Medicine Research Institute

Management Measures for Young and Middle-aged Physicians' Research Fund Projects

Article 1: The MGBlab Gut-Brain Laboratory has established the "Microecological Health and Medicine Research Institute Young Physician Research Fund" to initiate and collaborate on clinical research, promoting the integration of microbiology and traditional medicine, and facilitating the transformation and application of breast milk-derived strains. The fund is mainly used for research projects. The project directions include but are not limited to growth and development, mental/psychological, obesity, and immunity, aiming to explore the potential value of breast milk-derived strains in improving related diseases and providing scientific basis and standard recommendations for probiotic clinical applications.

Article 2: The MGBlab Gut-Brain Laboratory is responsible for the management of the fund's operation. Its specific duties are as follows:

1. Determine the direction of the fund's bidding, and organize the release of specific matters related to the fund application;

2. Verify the authenticity of the application materials submitted by the applicants or project leaders;

3. Organize industry experts to conduct professional reviews of the project applications, and ensure that the reviews are fair and impartial;

4. Supervise the use of fund funds, track, monitor, inspect, and accept the implementation of the fund cooperation projects.

Article 3: The application and review procedures of the fund are carried out in accordance with the national natural science foundation review procedures. It adopts the method of individual application, expert review, and MGBlab Gut-Brain Laboratory's approval. Projects are selected based on the best application.

Article 4: The MGBlab Gut-Brain Laboratory invites industry experts with high academic levels and good professional ethics to review the applications for fund cooperation projects.

Article 5: The supporting unit of the project applicant must have independent legal person status and be a research institution or an institution with research capabilities, such as the disease control system, universities, hospitals, or other research institutions. The application form filled out by the applicant must be stamped and confirmed by the scientific research management department of the affiliated unit and the competent unit.

Article 6: The applicant must be the actual project leader of the application, having a bachelor's degree or above and a mid-to-senior professional title or equivalent qualifications, with experience in conducting research in related disciplines such as medicine, nutrition, health education, or food/pharmaceutical science, and having achieved certain research results in this field.

Article 7: MGBlab Gut-Brain Laboratory is responsible for the initial review of all application projects. Those that do not meet the requirements for support by the fund will not be reviewed.

1. Do not conform to the research field supported by the fund;

2. The application procedures are incomplete, and the "Application Form" is not filled out in accordance with the regulations;

3. The application funds are excessive, and the fund cannot support it;

4. The applicant has applied for a fund cooperation project whose research content has already received other funding.

Article 8: For the application forms that pass the initial review, the laboratory first conducts a written review by experts, and then organizes experts for a meeting review. The review opinions raised by the meeting review should be voted on.

Article 9: MGBlab Gut-Brain Laboratory decides on the research projects to be cooperated based on the provisions of this regulation and the review opinions raised by the experts.

Article 10: The project leader of the winning project must fill in the project plan within 20 days from receiving the fund winning notification and submit it to MGBlab Gut-Brain Laboratory for approval.

Article 11: The recipient project leader should sign the "Microecological Health and Medicine Research Institute Young Physician Research Fund Project Cooperation Agreement" with MGBlab Gut-Brain Laboratory and abide by its implementation. 

Article 12 After the agreement is signed, the MGBlab Gut-Brain Laboratory will announce the names of the winning projects, the amount of support, the project leaders, and the names of the supporting institutions through the internet, public accounts, conferences, etc.

Article 13 MGBlab Gut-Brain Laboratory shall promptly disburse funds to the executing units of the cooperative projects in accordance with the "Cooperative Agreement for the Young Physician Research Fund of the Microecological Health and Medical Research Institute".

Article 14 The project leader shall carry out research work in accordance with the project plan, keep original records of the implementation of the fund cooperative project; within 30 days from the expiration of the project implementation period, submit a mid-term progress report to MGBlab Gut-Brain Laboratory; within 30 days from the expiration of the project implementation period, submit a complete final report to MGBlab Gut-Brain Laboratory. MGBlab Gut-Brain Laboratory shall review the mid-term report and final report of the project.

Article 15 For projects that fail to submit mid-term reports and final reports, have no progress, use funds improperly, fail to report and correct as required, etc., MGBlab Gut-Brain Laboratory may suspend or terminate the execution of the project at any time; MGBlab Gut-Brain Laboratory has the right to inspect the progress of the project and the use of the fund, and the researcher is obligated to cooperate.

Article 16 If the project leader or participants violate the provisions of this method and commit any of the following acts, MGBlab Gut-Brain Laboratory shall give a warning, suspend the disbursement of fund support funds, and order them to correct within a time limit; if they fail to correct within the time limit, the original cooperation decision shall be revoked, and the already disbursed fund support funds shall be recovered.

(1) Not conducting research in accordance with the project plan;

(2) Arbitrarily changing the research content or research plan;

(3) Failing to submit the annual progress report, final report or research results report as stipulated in these regulations;

(4) Submitting false reports, original records or related materials;

(5) Embezzling or misappropriating the fund support funds.

Article 17 When publishing research results obtained from the fund cooperative projects, it shall be indicated that they are supported by MGBlab Gut-Brain Laboratory/Microecological Health and Medical Research Institute's Young Physician Research Fund.

Article 18 The executors of the cooperative projects receiving the "Young Physician Research Fund of the Microecological Health and Medical Research Institute" are regarded as fully accepting all the provisions of this management method.

Article 19 This method shall come into effect from the date of promulgation, and MGBlab Gut-Brain Laboratory is responsible for the interpretation of this method.


Growth and Development Direction:

适应症

研究菌株

研究单位

项目名称

特发性矮小

BL-11

四川大学华西第二医院

动物双歧杆菌乳亚种BL-11干预特发性矮小儿童的安全性和有效性的前瞻性、随机、对照临床研究

ISS,IS,SGA

BL-11

武汉同济医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

武汉儿童医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

河北医科大学附属第一医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

江西省儿童医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

河北省儿童医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

上海瑞金医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

无锡儿童医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

北京儿研所

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

成都妇幼中心

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

ISS,IS,SGA

BL-11

南京儿童医院

动物双歧杆菌乳亚种 BL-11 改善矮小武汉同济医院/内分童身高的随机、双盲多中心临床研究

偏矮小儿童

BL-11

安医附二院

动物双歧杆菌乳亚种BL-11促进生长发育的临床观察

中重度营养不良

BL-11

大连市妇女儿童医疗中心

BL-11改善中重度营养不良

宫外发育迟缓EUGR

BL-11

上海市第六人民医院

乳双歧杆菌BL-11促进宫外发育迟缓儿生长发育的临床观察

 

Mental Health Direction:

适应症

研究菌株

研究单位

项目名称

 

情绪管理

LR99

山东体育学院

有氧运动及补充罗伊氏乳杆菌对大学生肠道菌群结构、短链脂肪酸含量及情绪压力的影响分析

注意力缺陷与多动障碍

LR99

四川省人民医院

LR99改善注意力缺陷与多动障碍症状的有效性与安全性研究

重性抑郁障碍

WIS32

天津安定医院

发酵粘液乳杆菌WIS32辅助治疗重性抑郁障碍的随机双盲安慰剂对照临床研究

孤独症谱系障碍

LR99

北京大学第六医院

罗伊氏粘液乳杆菌LR99联合行为干预改善孤独症谱系障碍儿童症状的随机双盲对照研究

注意力缺陷与多动障碍

蓝布谷

大连市妇女儿童医疗中心

母乳源菌株辅助哌甲酯治疗儿童注意缺陷与多动障碍的临床疗效评估及肠道微生物群的变化

 

Bone Health Direction:

适应症

研究菌株

研究单位

项目名称

 

骨质疏松症

BL-11

西南医科大学附属医院

动物双歧杆菌乳亚种BL-11改善老年骨质疏松症的临床研究

骨折

BL-11

上海市第六人民医院

动物双歧杆菌乳亚种BL-11促进骨折愈

 

 

Reproductive Health Direction:

适应症

研究菌株

研究单位

项目名称

 

辅助生育力

BL-11

海南生殖医学中心

动物双歧杆菌乳亚种BL-11用于提高体外受精-胚胎移植助孕女性生育力的临床研究

 

 

Intestinal Health Direction:

 

适应症

研究菌株

研究单位

项目名称

 

放射性肠炎

LL6

北京大学第一医院

益生菌预防和缓解前列腺癌病人放射性肠炎的随机双盲对照安慰剂临床研究



project proposal.1 project proposal.2
Contact Details
contact
  • PHONE:400-066-8611
  • EMAIL:
  • ADD:5th Floor, Building 5, Changping Life Valley Industrial Base, No. 79, Shuangying West Road, Science and Technology Park, Changping District, Beijing
Wemedia platform
Self media platform
  • MGBlab QR code
Copyright Information:Copyright © 2025 Zhongke Weizhi (Beijing) Biotechnology Co., Ltd. All Rights Reserved.
Registration Number: 京ICP备8888888号-2
  • PHONE:400-066-8611
  • EMAIL:
  • WeChatWeChat